Vaccine Dispensing in a Section of the Private Healthcare Sector in South Africa (2017–2021)
International Journal of Environmental Research and Public Health · 2025
DOI: 10.3390/ijerph22091329 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, 2025. Verfasst von Ilse Truter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Drug Utilization Research Unit (DURU), Department of Pharmacy, Faculty of Health Sciences, Nelson Mandela University, P.O. Box 77000, Gqeberha 6031, …. Hauptthemen laut MEDLINE: Private Sector, COVID-19, COVID-19 Vaccines, Vaccines. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The coronavirus disease 2019 (COVID-19) pandemic has put a renewed focus on the value of vaccines in combatting potentially life-threatening diseases. The primary aim was to conduct a longitudinal study on the dispensing patterns of vaccines (from 2017 to 2021) in a section of the private healthcare sector in South Africa. A descriptive cross-sectional pharmacoepidemiological study on health insurance data covering 5 years was conducted. The study included all vaccines available on the South African market (childhood, adult, travel, and other vaccines). The study population consisted of 3.8 million individuals. The descriptive statistics were calculated. The vaccine-dispensing patterns were distinctly different in 2021 compared to the preceding four years. The COVID-19 vaccine was introduced in 2021 in South Africa. Although the total number of medical insurance scheme members stayed relatively constant, the number of vaccine claims increased approximately seven-fold in 2021 compared to the average for the preceding four years (2017 to 2020). The tetanus and pneumococcal vaccines were the most dispensed bacterial vaccines, whilst the influenza and COVID-19 vaccines were the most dispensed viral vaccines. COVID-19 vaccines accounted for 55.74% of all vaccines dispensed over the 5 years, and for 85.70% of the vaccines dispensed in 2021. An increase in the number of bacterial vaccines dispensed was observed towards the middle of 2020, which was attributed to the pneumococcal vaccine. Pneumococcal vaccines were administered during the COVID-19 pandemic to prevent morbidity and mortality from co-/secondary infections and superinfections. Similar ongoing studies on vaccine-dispensing patterns in the post-COVID-19 era are necessary, especially since the outbreak of various vaccine-preventable diseases has recently been observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Utilization Research Unit (DURU), Department of Pharmacy, Faculty of Health Sciences, Nelson Mandela University, P.O. Box 77000, Gqeberha 6031, South Africa.
- Department of Statistics, Nelson Mandela University, P.O. Box 77000, Gqeberha 6031, South Africa.
- Quantium Health South Africa, We Work Building, 173 Oxford Road, Rosebank, Johannesburg 2196, South Africa.
- Quantium Health India, 1 Waverock Building, APIIC Nanakramguda, Serilingampally, Hyderabad 500032, Telangana, India.
ORCID-Profile: Ilse Truter
Zitieren
APA
Truter, I., Hugo, J., Smith, H., Bansal, S., & Vira, A. (2025). Vaccine Dispensing in a Section of the Private Healthcare Sector in South Africa (2017–2021). International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph22091329
Vancouver
Truter I, Hugo J, Smith H, Bansal S, Vira A. Vaccine Dispensing in a Section of the Private Healthcare Sector in South Africa (2017–2021). International Journal of Environmental Research and Public Health. 2025. doi:10.3390/ijerph22091329
BibTeX
@article{Truter2025,
author = {Truter, Ilse and Hugo, Johan and Smith, Hank and Bansal, Shailav and Vira, Alykhan},
title = {Vaccine Dispensing in a Section of the Private Healthcare Sector in South Africa (2017–2021)},
journal = {International Journal of Environmental Research and Public Health},
year = {2025},
doi = {10.3390/ijerph22091329}
}
EUVIMED